25
https://pubmed.ncbi.nlm.nih.gov/38113335
A noncanonical IRAK4-IRAK1 pathway, activated by DNA damage and independent of TLR/IL-1R signaling, inhibits apoptosis and may offer strategies to overcome tumor resistance to cancer treatments.